ישראל -
עברית -
Ministry of Health
equashield - closed system transfer device (cstd)
equashield medical ltd - אחות - the equashield™ drug reconstitution and transfer system is a contained system to be used by pharmacists or other health care professionals to prepare drugs, including cytotoxic drugs, for intravenous infusion or injection
ישראל -
עברית -
Ministry of Health
menopause home test kit
"פרומדיקו בע""מ" - כלל האוכלוסיה - ערכה לבדיקה ביתית למנופאוזה
ישראל -
עברית -
Ministry of Health
pelvic floor toning system
"פרומדיקו בע""מ" - כלל האוכלוסיה - מערכת לחיזוק שרירי רצפת האגן
ישראל -
עברית -
Ministry of Health
אקסלון מדבקה 10
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 9.5 mg/day - rivastigmine
ישראל -
עברית -
Ministry of Health
אקסלון מדבקה 15
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 27 mg - rivastigmine
ישראל -
עברית -
Ministry of Health
אקסלון מדבקה 5
novartis israel ltd - rivastigmine - מדבקות - rivastigmine 4.6 mg/day - rivastigmine
ישראל -
עברית -
Ministry of Health
סולנטרה
a.m.i. medical technologies limited, israel - ivermectin - קרם - ivermectin 1 %w/w - ivermectin
ישראל -
עברית -
Ministry of Health
מונטלוקאסט - תרימה 4 מג
trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 4 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.
ישראל -
עברית -
Ministry of Health
מונטלוקאסט - תרימה 5 מג
trima israel pharmaceutical products maabarot ltd - montelukast as sodium salt - טבליות לעיסות - montelukast as sodium salt 5 mg - montelukast - montelukast - montelukast - trima is indicated in adult and pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction. montelukast - trima is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. montelukast - trima and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. montelukast - trima is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older.